A detailed history of Ncm Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ncm Capital Management, LLC holds 32,246 shares of PFE stock, worth $885,475. This represents 0.49% of its overall portfolio holdings.

Number of Shares
32,246
Previous 34,523 6.6%
Holding current value
$885,475
Previous $958,000 5.85%
% of portfolio
0.49%
Previous 0.55%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $57,517 - $67,399
-2,277 Reduced 6.6%
32,246 $902,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $111,689 - $128,255
4,314 Added 14.28%
34,523 $958,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $33,394 - $43,375
-1,278 Reduced 4.06%
30,209 $869,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $9,177 - $10,727
-286 Reduced 0.9%
31,487 $1.04 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $1,553 - $1,796
43 Added 0.14%
31,773 $1.17 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $123,723 - $161,070
3,141 Added 10.99%
31,730 $1.3 Million
Q4 2022

Feb 15, 2023

SELL
$41.75 - $54.5 $11,272 - $14,715
-270 Reduced 0.94%
28,589 $1.47 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $7,264 - $8,867
-166 Reduced 0.57%
28,859 $1.26 Million
Q2 2022

Aug 17, 2022

SELL
$46.53 - $55.17 $7,910 - $9,378
-170 Reduced 0.58%
29,025 $1.52 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $18,345 - $22,732
-401 Reduced 1.35%
29,195 $1.51 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $1.22 Million - $1.81 Million
29,596 New
29,596 $1.75 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ncm Capital Management, LLC Portfolio

Follow Ncm Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ncm Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ncm Capital Management, LLC with notifications on news.